Evidence map›Paper›PMID 34018367›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2021

[Performance Verification of Plasma Renin and Aldosterone Examination with Chemiluminescence Immunoassay and Its Screening Efficacy for Primary Aldosteronism].

Zhi Liu, Mei Zhang, Yan Ren, Tao Chen, Hong-Jiao Gao, He He, Ayiligui, Ying Liu, Zhen-Mei An

Open access · greenAbstract read
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhi LiuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Mei ZhangDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Yan RenDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Tao ChenDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Hong-Jiao GaoDepartment of Endocrinology, the Third Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China.
He HeDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
AyiliguiDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Ying LiuDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhen-Mei AnDepartment of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the performance of chemiluminescence immunoassay (CLIA) in examining renin and aldosterone and to determine its value for screening for primary aldosteronism (PA).

methodsAccording to the relevant documents of Clinical and Laboratory Standards Institute (CLSI), we verified the precision, linear range and carryover rate of examining renin and aldosterone with CLIA. The study included 91 suspected PA patients, using two methods, CLIA and radioimmunoassay (RIA), to examine renin and aldosterone levels in order to compare the correlation between the two methods and their value for PA screening.

resultsThe precision, linear range and carryover rate of examining renin and aldosterone with CLIA met the requirements. In patients with suspected PA, the correlation coefficients of renin, aldosterone and aldosterone-to-renin ratio (ARR) assessed by CLIA and RIA were 0.901, 0.861 and 0.847 respectively (all

conclusionThe performance of the CLIA kit in assessing the concentration of renin and aldosterone meets the clinical requirements. Regarding preliminary PA screening, upright-position ARR had higher specificity, but lower sensitivity compared with supine-position ARR.

Indexed as

HyperaldosteronismHypertensionAldosteroneHumansImmunoassayLuminescenceReninAldosteroneReninAldosteroneChemiluminescence immunoassayPrimary aldosteronismRenin

Identifiers

PMID34018367
PMCPMC10409214
OpenAlexW3160534645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.